Skip to main content

Table 3 Summary of interventions and outcome measurements

From: Efficacy of conservative treatment for spastic cerebral palsy children with equinus gait: a systematic review and meta-analysis

Study

Intervention

Additional treatment

Follow-up (weeks)

Outcome measures

Baker et al. [27]

1. Placebo

2. Dysport;10–30 IU/Kg

Conventional PT and orthosis

16

- Mean of PROM of ankle DF (degrees)

- Mean score of GMFM dimensions D and E (points)

Bottos et al. [28]

1. Dysport + AFO

2. Dysport + Casting

- Dysport15-20 IU/Kg for both groups

Stretching, exercise, standing and gait training and provided AFO after BoNT-A

16

- Peak DF at stance (degrees)

Buckon et al. [29]

1. Control; no AFO

2. Hinged AFO, solid AFO, PLS;

6–12 h/day

No

12

- The 3D gait analysis data; kinematic (degrees)

- Mean of PROM of ankle DF (degrees)

- Mean score of GMFM dimensions D and E (points)

Corry et al. [9]

1. Casting; frequency of casting depended on clinical response

2. BoNT-A; 6–8 IU/Kg

No

12

- Mean composite scores of PRS

(4 subscales, total 10 points/limb)

- Mean of PROM of ankle DF (degrees)

- The 3D gait analysis data; Mean range of ankle DF at initial contact, peak DF at stance, peak PF (degrees)

Dalvand et al. [30]

1. Control

2. Hinged AFO, solid AFO; applied after casting

NDT 3 months (3 sessions per week, 1 h daily)

12

- Mean difference of mean score of GMFM dimension D and E (points)

Dursun et al.[13]

1. PT

2. BoNT-A + PT

- injected into the gastrocsoleus and tibialis posterior including hamstring and hip adductor 8–10 U/Kg

PT; Stretching, strengthening exercise, coordination training, training in daily activities

4

- Mean composite scores of CGAS (points)

Dursun et al. [31]

1. BoNT-A

2. BoNT-A + Casting

injected Dysport 10–40 IU/Kg into gastrocsoleus, Casting × 3 times/week

PT (improve functional mobility, stretching) and OT; 1 h/session, 5 sessions/week

12

- Mean composite scores of OGS (points)

- Mean of PROM of ankle DF (degrees)

El-Etribi et al. [20]

1. PT

2. BoNT-A + physiotherapy

injected BoNT-A 3 U/Kg for hemiplegia and 6 U/Kg for diplegia into gastrocnemius

Stretching, strengthening exercise

1–1.5 h/session,

3 days/weeks

12

- Mean composite scores of PRS

(6 subscales, total 14 points/limb)

- Mean of PROM of ankle DF (degrees)

Flett et al. [10]

1. Casting; lasted for 4 weeks; reapplied at 2 weeks

2. BoNT-A; 4–8 U/Kg injected into gastrocsoleus

Night plaster in both groups

48

- Mean composite scores of PRS

(2 subscales, total 7 points/limb)

- Mean of PROM of ankle DF (degrees)

- Mean score of GMFM dimension D,E (points)

Hayek et al. [32]

1. BoNT-A

2. BoNT-A + Casting

injected BoNT-A into gastrocnemius (total dose of 20 U/Kg) retained casting at 2 weeks for 4 months

- Conventional PT 3 times/week

- Brace

48

- Mean composite scores of OGS (points)

- Mean of PROM of ankle DF + KE (degrees)

- Mean of AROM of ankle DF (degrees)

- Mean score of GMFM dimension D,E (points)

Koman et al. [7]

1. Placebo

2. BoNT-A; injected into medial and lateral gastrocnemius for 1 U/Kg of hemiplegia, 2 U/Kg of diplegia

Conventional PT

6

- Number of improvements of PRS

(6 subscales, total 14 points/limb)

Koman et al. [23]

1. Placebo

2. BoNT-A; injected into medial and lateral gastrocnemius for 4 U/Kg of hemiplegia, 8 U/Kg of diplegia

Conventional PT

8

- Number of improvements of PRS

(6 subscales, total 14 points/limb)

Mass et al. [21]

1. Control; No KAFO at night

2. KAFO for at least 6 h/night

Physical therapy; gait and standing training

48

- Mean of PROM of ankle DF (degrees)

Radtka et al. [33]

1. Control; no AFO

2. Orthosis; solid AFO

8 subjects received PT

4

- Mean range of ankle DF at initial contact and mid-stance (degrees)

Radtka et al. [34]

1. Control; no AFO

3. Orthosis; solid and hinged AFO

Preventing

4

- Mean range of ankle DF at initial contact, mid-stance, terminal stance (degrees)

Rethlefsen et al. [35]

1. Control

2. Orthosis; fixed AFO, articulated AFO

None

6

- The 3D gait analysis data: mean of ankle DF at initial and terminal stance (degrees)

Sutherland et al. [12]

1. Placebo

2. BoNT-A; injected into gastrocnemius for 4 U/Kg of hemiplegia,

4 U/Kg × 2 times for diplegia

None

8

- Number improvement of ankle DF at initial contact (degrees)

- Number of improvements of VGA (graded 0–3 score, points)

-Mean difference of PROM of ankle DF (degrees)

Ubhi et al. [11]

1. Placebo

2. BoNT-A; injected Dysport

15 U/Kg for hemiplegia, 25 U/Kg for diplegia at gastrocsoleus

*3 cases were injected at hamstrings

Conventional PT with orthosis > 3 months before receive intervention

12

- Number of gait improvements of VGA (graded 0–4 score, points)

- Number of improvement of GMFM dimension E (points)

Xu et al. [36]

1. PT

2. BoNT-A + PT

- BoNT-A injected to ankle plantar flexors, 3 U/Kg for hemiplegia, 10 U/Kg for diplegia

- PT in both groups; orthosis, NDT, stretching, strength and coordination training and task-specific training, and electrical stimulation (ES) 1–1.5 h/session, 5 days/week for 2 weeks

None

12

- Mean of PROM of ankle DF (degrees)

- Mean score of GMFM dimension E (points)

Yigitoglu et al. [37]

1. BoNT- A

2. BoNT-A + electrical stimulation

- ES applied to the gastrocnemius muscle for 20 min/1 time, for 10 days

- BoNT-A10 U/Kg applied to the gastrocnemius and soleus muscles and home-based exercise programs for both groups

None

12

- Median of score of GMFM dimension E (points)

  1. BoNT-A, Botulinum toxin A; PROM, passive range of motion; DF, dorsiflexion; AFO, ankle–foot orthosis; KAFO, knee–ankle–foot orthosis; PLS, posterior leaf spring; NDT, neurodevelopment therapy; ES, electrical stimulation; PT, physical therapy; OT, occupational therapy; PRS, Physician’s Rating Scale; VGA, Video Gait Analysis; OGS, Observational Gait Scale; CGAS, Clinical Gait Assessment Score, PROM, passive range of motion; AROM, active range of motion; and GMFM, the Gross Motor Function Measure